Pharmacology and therapeutics of asthma and COPD
"The present volume is supposed to be a major reference resource for chest physicians and those involved in the development of novel pharmaceutical entities for these diseases. Internationally recognized authorities review the most important new information on the advances in our understanding...
Saved in:
Other Authors: | , |
---|---|
Format: | eBook |
Language: | English |
Published: |
Cham, Switzerland :
Springer,
[2017]
|
Series: | Handbook of experimental pharmacology ;
v. 237. |
Subjects: | |
ISBN: | 9783319521756 9783319521732 |
Physical Description: | 1 online resource (x, 288 pages) : illustrations |
LEADER | 04593cam a2200517Ia 4500 | ||
---|---|---|---|
001 | 97174 | ||
003 | CZ-ZlUTB | ||
005 | 20240914110406.0 | ||
006 | m o d | ||
007 | cr cnu---unuuu | ||
008 | 170211t20172017sz a ob 001 0 eng d | ||
040 | |a EBLCP |b eng |e pn |c EBLCP |d OCLCO |d MMU |d GW5XE |d N$T |d IDEBK |d YDX |d OCLCQ |d UAB |d OCLCO |d COO |d UPM |d IOG |d OCLCO |d MERER |d ESU |d Z5A |d OCLCO |d JBG |d IAD |d OCLCO |d ICW |d OCLCO |d ICN |d OCLCQ |d OCLCO |d NOC |d OTZ |d OCLCQ |d VT2 |d OCLCQ |d OCLCO |d TFH |d OCLCO |d OCLCQ |d JG0 |d OCLCO |d OCLCQ |d U3W |d OCLCO |d OCLCQ |d OCLCO |d CAUOI |d OCLCO |d OCLCQ |d OCLCO |d OCLCQ |d KSU |d CRU |d OCLCQ |d OCLCO |d OCLCQ |d OCLCO |d UKMGB |d OCLCO |d WYU |d OCLCO |d OCLCQ |d AU@ |d OCLCO |d UKAHL |d OCLCO |d OCLCQ |d ERF |d OCLCQ |d OCLCA |d OCLCQ |d UBY |d OCLCA |d OCLCQ |d ADU | ||
020 | |a 9783319521756 |q (electronic bk.) | ||
020 | |z 9783319521732 |q (hardcover ; |q alk. paper) | ||
024 | 7 | |a 10.1007/978-3-319-52175-6 |2 doi | |
035 | |a (OCoLC)972290140 |z (OCoLC)972150171 |z (OCoLC)972217297 |z (OCoLC)972405830 |z (OCoLC)972599644 |z (OCoLC)1005793680 |z (OCoLC)1048144340 |z (OCoLC)1112564603 |z (OCoLC)1160044051 |z (OCoLC)1162691831 | ||
245 | 0 | 0 | |a Pharmacology and therapeutics of asthma and COPD / |c Clive P. Page, Peter J. Barnes, editors. |
246 | 3 | |a Pharmacology and therapeutics of asthma and chronic obstructive pulmonary disease | |
264 | 1 | |a Cham, Switzerland : |b Springer, |c [2017] | |
264 | 4 | |c ©2017 | |
300 | |a 1 online resource (x, 288 pages) : |b illustrations | ||
336 | |a text |b txt |2 rdacontent | ||
336 | |a statický obraz |b sti |2 rdacontent | ||
337 | |a počítač |b c |2 rdamedia | ||
338 | |a online zdroj |b cr |2 rdacarrier | ||
490 | 1 | |a Handbook of experimental pharmacology, |x 1865-0325 ; |v volume 237 | |
500 | |a Revision of: Pharmacology and therapeutics of asthma and COPD / editors, Clive P. Page and Peter J. Barnes. ©2004. | ||
504 | |a Includes bibliographical references and index. | ||
505 | 0 | |a Pathogenesis of COPD and asthma / Clive Page, Blaze O'Shaughnessy, Peter Barnes -- [Beta] 2 agonists / Charlotte K. Billington, Raymond B. Penn, Ian P. Hall -- Muscarinic Receptor Antagonists / Maria Gabriella Matera, Mario Cazzola -- Xanthines and phosphodiesterase inhibitors / D. Spina, C.P. Page -- Glucocorticosteroids / Peter J. Barnes -- Fixed-dose combination inhalers / Mario Cazzola, Maria Gabriella Matera -- Anti-IgE and biologic approaches for the treatment of asthma / Patrick D. Mitchell, Amani I. El-Gammal, Paul M. O'Byrne -- Leukotriene receptor antagonists and antiallergy drugs / Tsutomu Tamada, Masakazu Ichinose -- Glucocorticoids / Ian M. Adcock, Sharon Mumby -- Bifunctional drugs for the treatment of respiratory diseases / Clive Page, Mario Cazzola -- Drugs affecting TRP channels / M.A. Wortley, M.A. Birrell, M.G. Belvisi -- Evaluation of new drugs for asthma and COPD: endpoints, biomarkers and clinical trial design / Dave Singh -- Drug delivery devices for inhaled medicines / Anne Lexmond, Ben Forbes. | |
506 | |a Plný text je dostupný pouze z IP adres počítačů Univerzity Tomáše Bati ve Zlíně nebo vzdáleným přístupem pro zaměstnance a studenty | ||
520 | |a "The present volume is supposed to be a major reference resource for chest physicians and those involved in the development of novel pharmaceutical entities for these diseases. Internationally recognized authorities review the most important new information on the advances in our understanding of the pathogenesis and treatment of these diseases, including the substantial advances in the topical delivery of inhaled medicines. Each chapter is extensively referenced, generously illustrated with clear diagrams and photographs, and represents a state-of-the-art review of this important area of respiratory medicine"--Publisher's description. | ||
590 | |a SpringerLink |b Springer Complete eBooks | ||
650 | 0 | |a Asthma |x Chemotherapy. | |
650 | 0 | |a Lungs |x Diseases, Obstructive |x Chemotherapy. | |
650 | 0 | |a Antiasthmatic agents. | |
655 | 7 | |a elektronické knihy |7 fd186907 |2 czenas | |
655 | 9 | |a electronic books |2 eczenas | |
700 | 1 | |a Barnes, Peter J., |d 1946- |e editor. | |
700 | 1 | |a Page, C. P., |e editor. | |
730 | 0 | |i Preceded by: |a Pharmacology and therapeutics of asthma and COPD. | |
776 | 0 | 8 | |i Print version: |t Pharmacology and therapeutics of asthma and COPD. |d Cham, Switzerland : Springer, [2017] |z 9783319521756 |w (OCoLC)966239426 |
830 | 0 | |a Handbook of experimental pharmacology ; |v v. 237. |x 0171-2004 | |
856 | 4 | 0 | |u https://proxy.k.utb.cz/login?url=https://link.springer.com/10.1007/978-3-319-52175-6 |y Plný text |
992 | |c NTK-SpringerBLS | ||
999 | |c 97174 |d 97174 | ||
993 | |x NEPOSILAT |y EIZ |